Physician profile
John Funke
NPI 1982668646
$337.94
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.78 · 2020: $40.83 · 2022: $123 · 2023: $76.13 · 2024: $18.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $122.77 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $36.47 | 2023-2024 | Libtayo |
| Astellas Pharma US INC | $24.84 | 2019-2020 | |
| Acrotech Biopharma INC. | $21.95 | 2023 | Beleodaq |
| Pharmacyclics LLC, An Abbvie Company | $18.65 | 2019 | |
| Blue Earth Diagnostics | $18.50 | 2023 | |
| Incyte Corporation | $17.64 | 2023 | Monjuvi, Jakafi, Pemazyre |
| Ipsen Biopharmaceuticals, INC | $17.16 | 2019 | |
| Carl Zeiss Meditec, INC. | $15.84 | 2019 | |
| Janssen Biotech, INC. | $14.92 | 2019 | |
| Merck Sharp & Dohme LLC | $14.61 | 2020 | |
| Dova Pharmaceuticals | $14.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Funke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.